Symbols

CVSA

Covista·NYSE

--(--)

CVSA fundamentals

CVSA Q2 2026 Earnings

Covista (CVSA) released its earnings on Jan 28, 2026: revenue was 503.38M (YoY +12.43%), beat estimates; EPS was 2.43 (YoY +34.25%), beat estimates.

Revenue / YoY

503.38M

+12.43%

EPS / YoY

2.43

+34.25%

Report date

Jan 28, 2026

CVSA Earnings Call Summary for Q2,2026

Revenue & EPS Growth: 12.4% YoY revenue to $503.4M, EPS up 34% to $2.43. Raised FY26 EPS guidance to 17-20% growth.
Enrollment Strength: 97,000 total students (+6% YoY), Walden at 52,400 (+13% YoY), Chamberlain 40,000 nursing students.
Strategic Wins: New programs enroll 1,200+ students, Med/Vet EBITDA margin +280bps, $728M buyback authorization.
Upcoming Catalysts: Investor Day on Feb 24 to detail multiyear growth framework.

Earnings

EPS

Revenue

Revenue & Expenses

CVSA has released its 2026 Q2 earnings report, with revenue of 503.38M, reflecting a YoY change of 12.43%, and net profit of 76.38M, showing a YoY change of 0.69%. The Sankey diagram below clearly presents CVSA's revenue sources and cost distribution.

Key Indicators

Covista (CVSA) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Covista (CVSA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Covista (CVSA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Covista (CVSA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown